Trial intelligence / Profile preview

Milrinone vs Epinephrine for RV Dysfunction After Cardiac Surgery

NCT07144267Recruiting

Sponsor
Mansoura University
Start
Mar 2026
Primary completion
Dec 2028
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of milrinone in Right ventricular dysfunction (RVD) (2 arms), sponsored by Mansoura University. Primary endpoint: Change in Tricuspid annular plane systolic excursion. Started Mar 2026; status: recruiting.

02

Drugs

milrinone
03

Conditions

Right ventricular dysfunction (RVD)

Beyond the preview

Go deeper on NCT07144267.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07144267.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call